Cite
Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.
MLA
Skouras, Vasileios S., et al. “Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.” BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 30, no. 5, Oct. 2016, pp. 421–39. EBSCOhost, https://doi.org/10.1007/s40259-016-0194-1.
APA
Skouras, V. S., Maragkos, C., Grapsa, D., & Syrigos, K. N. (2016). Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer. BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 30(5), 421–439. https://doi.org/10.1007/s40259-016-0194-1
Chicago
Skouras, Vasileios S, Charis Maragkos, Dimitra Grapsa, and Konstantinos N Syrigos. 2016. “Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.” BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 30 (5): 421–39. doi:10.1007/s40259-016-0194-1.